Literature DB >> 34430537

Perioperative immunotherapy for pancreatic cancer is on its way.

Christoph Springfeld1, Peter Bailey2,3, Thilo Hackert2, John P Neoptolemos2.   

Abstract

Entities:  

Year:  2021        PMID: 34430537      PMCID: PMC8350999          DOI: 10.21037/hbsn-21-238

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

1.  Genomic analyses identify molecular subtypes of pancreatic cancer.

Authors:  Peter Bailey; David K Chang; Katia Nones; Amber L Johns; Ann-Marie Patch; Marie-Claude Gingras; David K Miller; Angelika N Christ; Tim J C Bruxner; Michael C Quinn; Craig Nourse; L Charles Murtaugh; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Ehsan Nourbakhsh; Shivangi Wani; Lynn Fink; Oliver Holmes; Venessa Chin; Matthew J Anderson; Stephen Kazakoff; Conrad Leonard; Felicity Newell; Nick Waddell; Scott Wood; Qinying Xu; Peter J Wilson; Nicole Cloonan; Karin S Kassahn; Darrin Taylor; Kelly Quek; Alan Robertson; Lorena Pantano; Laura Mincarelli; Luis N Sanchez; Lisa Evers; Jianmin Wu; Mark Pinese; Mark J Cowley; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Lorraine A Chantrill; Amanda Mawson; Jeremy Humphris; Angela Chou; Marina Pajic; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Lovell; Neil D Merrett; Christopher W Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Kim Moran-Jones; Nigel B Jamieson; Janet S Graham; Fraser Duthie; Karin Oien; Jane Hair; Robert Grützmann; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Borislav Rusev; Paola Capelli; Roberto Salvia; Giampaolo Tortora; Debabrata Mukhopadhyay; Gloria M Petersen; Donna M Munzy; William E Fisher; Saadia A Karim; James R Eshleman; Ralph H Hruban; Christian Pilarsky; Jennifer P Morton; Owen J Sansom; Aldo Scarpa; Elizabeth A Musgrove; Ulla-Maja Hagbo Bailey; Oliver Hofmann; Robert L Sutherland; David A Wheeler; Anthony J Gill; Richard A Gibbs; John V Pearson; Nicola Waddell; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

2.  ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.

Authors:  Joanne Leung; Luis A Rojas; Jennifer Ruan; John Alec Moral; Julia Zhao; Zachary Sethna; Anita Ramnarain; Billel Gasmi; Murali Gururajan; David Redmond; Gokce Askan; Umesh Bhanot; Ela Elyada; Youngkyu Park; David A Tuveson; Mithat Gönen; Steven D Leach; Jedd D Wolchok; Ronald P DeMatteo; Taha Merghoub; Vinod P Balachandran
Journal:  Nature       Date:  2020-02-19       Impact factor: 49.962

3.  Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Authors:  Vinod P Balachandran; Marta Łuksza; Julia N Zhao; Vladimir Makarov; John Alec Moral; Romain Remark; Brian Herbst; Gokce Askan; Umesh Bhanot; Yasin Senbabaoglu; Daniel K Wells; Charles Ian Ormsby Cary; Olivera Grbovic-Huezo; Marc Attiyeh; Benjamin Medina; Jennifer Zhang; Jennifer Loo; Joseph Saglimbeni; Mohsen Abu-Akeel; Roberta Zappasodi; Nadeem Riaz; Martin Smoragiewicz; Z Larkin Kelley; Olca Basturk; Mithat Gönen; Arnold J Levine; Peter J Allen; Douglas T Fearon; Miriam Merad; Sacha Gnjatic; Christine A Iacobuzio-Donahue; Jedd D Wolchok; Ronald P DeMatteo; Timothy A Chan; Benjamin D Greenbaum; Taha Merghoub; Steven D Leach
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

Review 4.  Adjuvant treatment for pancreatic cancer.

Authors:  Ulla Klaiber; Thilo Hackert; John P Neoptolemos
Journal:  Transl Gastroenterol Hepatol       Date:  2019-04-29

5.  BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial.

Authors:  Bruno Bockorny; Valerya Semenisty; Teresa Macarulla; Erkut Borazanci; Brian M Wolpin; Salomon M Stemmer; Talia Golan; Ravit Geva; Mitesh J Borad; Katrina S Pedersen; Joon Oh Park; Robert A Ramirez; David G Abad; Jaime Feliu; Andres Muñoz; Mariano Ponz-Sarvise; Amnon Peled; Tzipora M Lustig; Osnat Bohana-Kashtan; Stephen M Shaw; Ella Sorani; Marya Chaney; Shaul Kadosh; Abi Vainstein Haras; Daniel D Von Hoff; Manuel Hidalgo
Journal:  Nat Med       Date:  2020-05-25       Impact factor: 53.440

6.  A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer.

Authors:  Masayuki Imamura; Ryuichiro Doi; Toshihide Imaizumi; Akihiro Funakoshi; Hideyuki Wakasugi; Makoto Sunamura; Yoshiro Ogata; Shoichi Hishinuma; Takehide Asano; Takashi Aikou; Ryo Hosotani; Shunzo Maetani
Journal:  Surgery       Date:  2004-11       Impact factor: 3.982

7.  Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.

Authors:  Lena Seifert; Gregor Werba; Shaun Tiwari; Nancy Ngoc Giao Ly; Susanna Nguy; Sara Alothman; Dalia Alqunaibit; Antonina Avanzi; Donnele Daley; Rocky Barilla; Daniel Tippens; Alejandro Torres-Hernandez; Mautin Hundeyin; Vishnu R Mani; Cristina Hajdu; Ilenia Pellicciotta; Philmo Oh; Kevin Du; George Miller
Journal:  Gastroenterology       Date:  2016-03-03       Impact factor: 22.682

Review 8.  Challenges and Opportunities for Pancreatic Cancer Immunotherapy.

Authors:  Adham S Bear; Robert H Vonderheide; Mark H O'Hara
Journal:  Cancer Cell       Date:  2020-09-17       Impact factor: 31.743

9.  CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype.

Authors:  Juliana B Candido; Jennifer P Morton; Peter Bailey; Andrew D Campbell; Saadia A Karim; Thomas Jamieson; Laura Lapienyte; Aarthi Gopinathan; William Clark; Ewan J McGhee; Jun Wang; Monica Escorcio-Correia; Raphael Zollinger; Rozita Roshani; Lisa Drew; Loveena Rishi; Rebecca Arkell; T R Jeffry Evans; Colin Nixon; Duncan I Jodrell; Robert W Wilkinson; Andrew V Biankin; Simon T Barry; Frances R Balkwill; Owen J Sansom
Journal:  Cell Rep       Date:  2018-05-01       Impact factor: 9.423

10.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Colin W Steele; Saadia A Karim; Joshua D G Leach; Peter Bailey; Rosanna Upstill-Goddard; Loveena Rishi; Mona Foth; Sheila Bryson; Karen McDaid; Zena Wilson; Catherine Eberlein; Juliana B Candido; Mairi Clarke; Colin Nixon; John Connelly; Nigel Jamieson; C Ross Carter; Frances Balkwill; David K Chang; T R Jeffry Evans; Douglas Strathdee; Andrew V Biankin; Robert J B Nibbs; Simon T Barry; Owen J Sansom; Jennifer P Morton
Journal:  Cancer Cell       Date:  2016-06-02       Impact factor: 38.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.